
Medplus Health Services: Analytical Review Highlights Key Shifts in Market Assessment
2025-11-27 08:17:46Medplus Health Services, a prominent player in the retailing sector, has undergone a notable revision in its market evaluation, reflecting nuanced changes across quality, valuation, financial trends, and technical indicators. This article delves into the factors influencing the recent shift in analytical perspective, providing investors with a comprehensive understanding of the company’s current standing amid evolving market dynamics.
Read MoreHow has been the historical performance of Medplus Health?
2025-11-26 22:50:53Revenue and Profit Growth Medplus Health’s net sales have shown a robust upward trajectory, increasing from ₹2,870.60 crores in March 2020 to ₹6,136.05 crores by March 2025. This represents a compound annual growth rate (CAGR) of approximately 17.5%, reflecting strong market demand and expansion. Total operating income mirrored this growth, as other operating income remained nil throughout the period. Operating profit before depreciation and interest (PBDIT) excluding other income rose from ₹133.68 crores in 2020 to ₹487.10 crores in 2025, indicating improved operational efficiency. Including other income, operating profit increased to ₹535.72 crores in the latest fiscal year. Despite rising interest costs, which climbed from ₹46.80 crores to ₹102.59 crores, the compan...
Read MoreIs Medplus Health technically bullish or bearish?
2025-11-25 09:05:44Overview of Recent Price Movements and Trend Changes Medplus Health, a key player in the retailing sector, has seen its technical trend evolve from bearish to mildly bearish as of 24 November 2025. The stock closed at ₹795.10, up from the previous close of ₹766.85, with intraday highs reaching ₹806.15 and lows at ₹773.30. Despite this uptick, the stock remains well below its 52-week high of ₹1,052.05, though comfortably above its 52-week low of ₹603.00. This price action reflects a tentative recovery phase, yet the overall technical landscape remains cautious. The shift to mildly bearish suggests that while the downtrend may be losing momentum, a definitive bullish reversal has yet to materialise. Technical Indicators: A Mixed Bag Examini...
Read More
Medplus Health Services Sees Shift in Technical Momentum Amid Mixed Market Signals
2025-11-25 08:15:00Medplus Health Services has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. The stock’s recent price movements and technical parameters suggest a nuanced outlook for investors within the retailing sector.
Read More
Medplus Health Services: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals
2025-11-24 08:12:10Medplus Health Services has experienced a revision in its market assessment following a detailed analysis of its quality, valuation, financial trends, and technical indicators. The company’s recent performance presents a complex picture, with positive quarterly results tempered by longer-term fundamental challenges and evolving technical signals.
Read More
Medplus Health Services Faces Bearish Momentum Amid Technical Shifts
2025-11-24 08:06:08Medplus Health Services has experienced a notable shift in its technical momentum, with recent market data indicating a transition towards bearish trends across multiple timeframes. This development comes amid a broader context of subdued price performance relative to benchmark indices, prompting a closer examination of key technical indicators and price action.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
31-Jan-2026 | Source : BSESubmission of Newspaper Clippings
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
31-Jan-2026 | Source : BSEUpdate under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Board Meeting Outcome For Un-Audited Financial Results Of The Company For The Quarter Ended December 31 2025
30-Jan-2026 | Source : BSEOutcome for Board Meeting held today i.e. January 30 2026 for the quarter ended December 31 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available